278 material Form 8-K filings that 243 companies we cover made with the SEC in May 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Rush Street Interactive reported first-quarter 2024 revenue of $217.4 million, up 34% from a year earlier, and a net loss of $2.2 million, down from $24.5 million. The company also raised its full-year 2024 Adjusted EBITDA guidance to between $50 million and $60 million, a midpoint increase of $15 million, which signals higher expected profitability for shareholders.
Q1 2024 revenue was $217.4 million, up 34% from $162.4 million in Q1 2023.
Q1 2024 net loss was $2.2 million, compared with $24.5 million in Q1 2023; net loss per share was $(0.01) versus $(0.11).
Q1 2024 Adjusted EBITDA was $17.1 million, compared with a loss of $8.7 million a year earlier.
Full-year 2024 Adjusted EBITDA guidance is $50 million to $60 million, with the midpoint raised by $15 million; revenue guidance is $810 million to $860 million, with the midpoint raised by $35 million.
Digi International reported second fiscal quarter 2024 revenue of $108 million, down 3% from a year earlier, and net income of $4 million, down from $6 million. The company lowered its fiscal 2024 Adjusted EBITDA range and now projects revenue down 5% year over year, citing customers who are more cautious on second half demand and longer sales cycles.
Q2 revenue was $108 million, down 3%; diluted EPS was $0.11 versus $0.16, and adjusted diluted EPS was $0.49, flat year over year
Company accrued an approximate $6 million liability for pending litigation in the quarter
Fiscal 2024 revenue is projected to be down 5% year over year; Adjusted EBITDA range lowered slightly
Third quarter revenue guidance is $103 million to $107 million, with adjusted diluted EPS of $0.47 to $0.51
Enact reported net income of $161.0 million, or $1.01 per diluted share, for the quarter ended March 31, 2024, down from $176.0 million and $1.08 a year earlier, even though total revenues rose to $291.6 million from $280.9 million. The board also raised the quarterly dividend to $0.185 per share and authorized a new buyback of up to $250 million, which adds to the existing $100 million program.
Q1 2024 net income was $161.0 million ($1.01 per diluted share), versus $176.0 million ($1.08) in Q1 2023.
Total revenues were $291.6 million, versus $280.9 million in Q1 2023.
Adjusted operating income was $166.2 million, or $1.04 per diluted share, versus $1.08 a year earlier.
The dividend is $0.185 per share, payable June 13, 2024 to holders of record on May 29, 2024; $24 million remained under the existing $100 million buyback as of April 26, 2024.
Comstock Resources reported a first-quarter 2024 net loss of $14.5 million, or $0.05 per share, compared with net income of $134.5 million, or $0.49 per diluted share, a year earlier. Total revenues fell to $335.8 million from $489.6 million, and the company said continued weak natural gas prices weighed heavily on results, which matters to shareholders because earnings and cash flow both declined sharply.
Total revenues were $335.8 million, down from $489.6 million in the first quarter of 2023.
Net loss was $14.5 million, or $0.05 per share, versus net income of $134.5 million, or $0.49 per diluted share, a year earlier.
Adjusted net loss was $8.5 million, or $0.03 per share; adjusted EBITDAX was $230 million versus $293.5 million.
Average natural gas price was $2.06 per Mcf, down from $2.98, and operating cash flow was $182.0 million versus $254.9 million.
First Solar reported first quarter 2024 net sales of $794 million and diluted EPS of $2.20, down from the fourth quarter of 2023 but up sharply from a year earlier. The company kept its full-year 2024 net sales, gross margin, operating income and EPS guidance unchanged, but cut its expected year-end net cash balance to $600 million to $900 million and raised its capital expenditure forecast to $1.8 billion to $2.0 billion.
Q1 2024 net sales of $794 million, down $0.4 billion from the prior quarter and up from $548 million in Q1 2023
Diluted EPS of $2.20 versus $3.25 in Q4 2023 and $0.40 in Q1 2023; net income of $236.6 million
2024 guidance: net sales $4.4 billion to $4.6 billion and EPS $13.00 to $14.00 unchanged; net cash balance lowered to $600 million to $900 million from $0.9 billion to $1.2 billion
Capital expenditure guidance raised to $1.8 billion to $2.0 billion from $1.7 billion to $1.9 billion; cash less debt fell to $1.4 billion from $1.6 billion
Glaukos reported first quarter 2024 net sales of $85.6 million, up 16% from $73.9 million a year earlier, and raised its full-year 2024 net sales guidance to $357 million to $365 million from $350 million to $360 million. The GAAP net loss widened to $40.8 million, or $0.82 per share, from $34.6 million, or $0.72 per share, in the same period of 2023, including an $11.7 million acquired in-process R&D charge that the company excluded from its non-GAAP results.
Q1 2024 net sales were $85.6 million, up 16% on both a reported and constant currency basis.
GAAP net loss was $40.8 million, or $(0.82) per diluted share, versus $34.6 million, or $(0.72), in Q1 2023.
Non-GAAP net loss was $34.6 million, or $(0.70) per diluted share, including an $11.7 million acquired in-process R&D charge.
Cash, cash equivalents, short-term investments and restricted cash were about $278.7 million as of March 31, 2024, versus $301.3 million at December 31, 2023.
Kulicke & Soffa reported fiscal second-quarter 2024 net revenue of $172.1 million, down 0.5% from a year earlier, and a net loss of $102.7 million, or $(1.83) per diluted share, compared with net income of $15.0 million a year earlier. The loss reflects pre-tax charges tied to the cancellation of Project W, and the company expects third-quarter net revenue of about $180 million with GAAP diluted EPS of about $0.17.
Net revenue of $172.1 million, down 0.5% from $173.0 million in the same quarter last year.
Net loss of $102.7 million, or $(1.83) per diluted share; non-GAAP net loss was $53.2 million, or $(0.95) per share.
Pre-tax charges related to Project W totaled $105.5 million, including a $44.5 million impairment charge.
Third-quarter fiscal 2024 outlook: net revenue of about $180 million +/- $10 million and GAAP diluted EPS of about $0.17 +/- 10%.
Gates Industrial reported first-quarter 2024 net sales of $862.6 million, down 3.9% from a year earlier, while net income attributable to shareholders rose to $40.0 million, or $0.15 per diluted share, from $26.4 million, or $0.09. The company raised its full-year 2024 Adjusted EBITDA guidance to $745 million to $805 million from $725 million to $785 million, which matters to shareholders because it signals stronger expected profitability despite softer sales.
Q1 2024 net sales were $862.6 million, down 3.9%, with a core revenue decline of 3.6%.
Adjusted EBITDA rose to $195.6 million from $174.5 million, and the margin widened to 22.7% from 19.4%.
Adjusted EPS was $0.31 versus $0.25 a year earlier, despite a higher effective tax rate.
Full-year 2024 Adjusted EBITDA guidance was raised to $745 million to $805 million from $725 million to $785 million; other guidance metrics were unchanged.
Vita Coco reported first quarter 2024 net sales up 2% to $112 million, with net income of $14 million, or $0.24 per diluted share, compared with $7 million, or $0.12, a year earlier. The company raised its full-year 2024 guidance to net sales of $500 million to $510 million and Adjusted EBITDA of $76 million to $82 million, but said higher ocean freight costs will weigh on gross margins starting in the second quarter.
Q1 2024 net sales rose 2% to $112 million, and gross margin rose to 42.2% from 30.7%.
Q1 2024 Adjusted EBITDA was $21 million, compared with $9 million in the same period of 2023.
2024 guidance: net sales of $500 million to $510 million, Adjusted EBITDA of $76 million to $82 million, and full-year gross margin of 37% to 39%.
Extreme Networks reported fiscal third-quarter 2024 results for the quarter ended March 31, 2024. Revenue fell 36.5% year over year to $211.0 million, and the company posted a GAAP net loss of $64.4 million, or $0.50 per diluted share, compared with earnings of $0.17 per share a year earlier. For shareholders, the sharp revenue decline and loss weigh on the results, though the company guided to sequential revenue growth of $250.0 million to $260.0 million for the fourth quarter.
Revenue was $211.0 million, down from $332.5 million a year earlier; SaaS ARR rose 38.0% to $162.0 million
GAAP net loss was $64.4 million ($0.50 per diluted share), versus net income of $22.1 million a year earlier
Quarter-end cash was $151.0 million; free cash flow was negative $73.6 million for the quarter
Fourth-quarter fiscal 2024 revenue guidance is $250.0 million to $260.0 million; GAAP EPS guidance is ($0.11) to ($0.05)
Marriott reported first quarter 2024 results with total revenues up 6% to $5,977 million, but reported diluted EPS fell to $1.93 from $2.43 and reported net income fell to $564 million from $757 million. The company raised its full-year 2024 adjusted EPS outlook to $9.31 to $9.65 and expects to return $4.2 billion to $4.4 billion to shareholders in 2024.
Adjusted diluted EPS rose to $2.13 from $2.09; adjusted net income fell to $620 million from $648 million.
Worldwide comparable systemwide constant dollar RevPAR rose 4.2%, with U.S. & Canada up 1.5% and international markets up 11.1%.
Full-year 2024 adjusted EBITDA outlook is $4,960 million to $5,090 million; investment spending is $1,000 million to $1,200 million.
Marriott repurchased 4.8 million shares for $1.2 billion in the first quarter.
TG Therapeutics reported first quarter 2024 total revenue of $63.5 million, up from $7.8 million a year earlier, and a net loss of $10.7 million, down from $39.2 million. The company raised its full-year 2024 U.S. BRIUMVI net product revenue target to $270 million to $290 million, from $220 million to $260 million previously.
Q1 2024 total revenue of $63.5 million, including a $12.5 million milestone payment tied to the first EU launch of BRIUMVI in Germany
Q1 2024 U.S. BRIUMVI net product revenue of $50.5 million; company targets approximately $65 million for Q2 2024
Net loss of $10.7 million, or $0.07 per share, versus $39.2 million, or $0.28 per share, in Q1 2023
Cash, cash equivalents and investment securities of $209.8 million as of March 31, 2024
OneSpaWorld reported first-quarter 2024 total revenues of $211.2 million, up 16% from a year earlier, and net income of $21.2 million, or $0.21 per diluted share, compared with a net loss of $15.9 million, or $0.17 per share, a year earlier. The company raised its fiscal 2024 revenue guidance to $860 million to $880 million and its adjusted EBITDA guidance to $95 million to $105 million, and its board approved a $50 million share repurchase program. Net income includes a $7.7 million gain from the change in fair value of warrant liabilities.
Income from operations rose 52% to $17.0 million; adjusted EBITDA rose 31% to $25.3 million from $19.3 million.
Fiscal 2024 revenue guidance raised to $860-$880 million from $850-$870 million.
Fiscal 2024 adjusted EBITDA guidance raised to $95-$105 million from $90-$100 million.
Board approved a share repurchase program of up to $50 million; cash at March 31, 2024 was $66.6 million.
Parsons reported first-quarter 2024 revenue of $1.5 billion, up 31% from a year earlier, and raised its fiscal 2024 revenue, adjusted EBITDA, and operating cash flow guidance. The company posted a net loss of $107 million because of a $214 million pre-tax charge tied to repurchasing part of its 2025 convertible notes, so shareholders see stronger operations offset by a large one-time loss.
Revenue of $1.5 billion, up $362 million or 31% year over year; adjusted EBITDA of $141 million, up 56%
Net loss of $107 million, or $1.01 per diluted share, including a $214 million pre-tax charge on convertible note repurchases; excluding that charge, diluted EPS would have been $0.49
Fiscal 2024 revenue guidance raised to $6.1 billion-$6.4 billion from $5.8 billion-$6.0 billion; adjusted EBITDA guidance raised to $535 million-$575 million
Total backlog of $9.0 billion, up 8%; book-to-bill ratio of 1.4x on $2.1 billion of net bookings
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.